Brain fMRT In Takotsubo Cardiomyopathy
- Conditions
- Takotsubo Cardiomyopathy
- Registration Number
- NCT02240056
- Lead Sponsor
- Wolfgang Dichtl, MD PhD
- Brief Summary
Certain cardiac and neurologic diseases influence each other via a still poorly understood "brain-heart axis". Subarachnoidal bleedings are well known to cause ECG alterations resembling those of myocardial infarction, along with a reduction of systolic myocardial function ("neurogenic stunned myocardium"). Alterations of the right insula region by a stroke or intracranial hemorrhage go along with a sympathetic activation (increased circulating catecholamine levels, tachycardia, arterial hypertension). In contrast, alterations of the left insula region often cause vagal reactions such as bradycardia, arterial hypotension. Takotsubo cardiomyopathy (TTC) is a just recently recognised subform of heart attacks, often caused by psychological or physical stress (death of a beloved one, divorce, job loss, infection, preoperative state). In more than 90% of cases, TTC affects postmenopausal women.
Functional MRT enables imaging of activated brain regions, either without ("resting state") or with specific stimuli. The investigators speculate that there is a specific involvement of the insula region during TTC.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 55
- Postmenopausal females aged below 90 years
- Informed written consent
- TTC or NSTEMI / STEMI undergoing coronary angiography within 24 hours of symptom onset
- Delayed coronary angiography (> 24 hours after symptom onset)
- Inability to perform rsfMRT within the first 72 hours after coronary angiography
- Inability to communicate in German language
- Contraindications for a MRT examination (including pacemaker, implantable cardioverter-defibrillator, mechanical heart valves, claustrophobia, severe adipositas)
- Drug addiction, under guardianship
- Inability to stick to the follow up examination
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in brain functional MRT (resting state, paradigma) in postmenopausal females suffering from TTC as compared to NSTEMI / STEMI postmenopausal female patients Within the first 72h after diagnosis and after 4-8 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Medical University Innsbruck
🇦🇹Innsbruck, Tirol, Austria